# Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

> **NCT06097832** · PHASE1,PHASE2 · RECRUITING · sponsor: **Nexcella Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Light Chain (AL) Amyloidosis

## Interventions

- **BIOLOGICAL:** NXC-201 CAR-T

## Key facts

- **NCT ID:** NCT06097832
- **Lead sponsor:** Nexcella Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-05
- **Primary completion:** 2026-12
- **Final completion:** 2039-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097832, "Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06097832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*